Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obesity

  Free Subscription


Articles published in Diabetes Metab

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    July 2022
  1. RIVIERE B, Jaussent A, Macioce V, Faure S, et al
    The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.
    Diabetes Metab. 2022;48:101345.
    PubMed     Abstract available


    June 2022
  2. VALENZUELA-VALLEJO L, Chrysafi P, Mantzoros CS
    Liraglutide-induced effects on energy intake and glycemic profile are independent of total and intact GDF-15 levels in subjects with obesity and diabetes.
    Diabetes Metab. 2022 Jun 28:101369. doi: 10.1016/j.diabet.2022.101369.
    PubMed    


  3. LEMBO E, Russo MF, Verrastro O, Anello D, et al
    Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.
    Diabetes Metab. 2022 Jun 24:101363. doi: 10.1016/j.diabet.2022.101363.
    PubMed     Abstract available


    May 2022
  4. XI Y, Gao W, Zheng K, Lv J, et al
    Overweight and risk of type 2 diabetes: A prospective Chinese twin study.
    Diabetes Metab. 2022;48:101278.
    PubMed     Abstract available


    January 2022
  5. KUMAR S, Khatri M
    Response to "A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass".
    Diabetes Metab. 2022;48:101302.
    PubMed     Abstract available


  6. MORICONI D, Manca ML, Anselmino M, Rebelos E, et al
    Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
    Diabetes Metab. 2022;48:101282.
    PubMed     Abstract available


  7. BI J, Song L, Wang L, Su B, et al
    Transitions in metabolic health status over time and risk of heart failure: A prospective study.
    Diabetes Metab. 2022;48:101266.
    PubMed     Abstract available


    November 2021
  8. BREDER I, Wolf VLW, Soares AAS, de Carvalho LSF, et al
    Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: an active-controlled randomised trial.
    Diabetes Metab. 2021 Nov 19:101304. doi: 10.1016/j.diabet.2021.101304.
    PubMed    


    March 2021
  9. PRANATA R, Lim MA, Yonas E, Vania R, et al
    Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis.
    Diabetes Metab. 2021;47:101178.
    PubMed     Abstract available


  10. LEON-MIMILA P, Villamil-Ramirez H, Li XS, Shih DM, et al
    Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
    Diabetes Metab. 2021;47:101183.
    PubMed     Abstract available


  11. LI F, Duan J, Yang Y, Yan G, et al
    Distinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population.
    Diabetes Metab. 2021;47:101175.
    PubMed     Abstract available


    September 2020
  12. MONNIER L, Schlienger JL, Colette C, Bonnet F, et al
    The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview.
    Diabetes Metab. 2020 Sep 28. pii: S1262-3636(20)30127.
    PubMed     Abstract available


    February 2020
  13. BOTHOU C, Beuschlein F, Spyroglou A
    Links between aldosterone excess and metabolic complications: A comprehensive review.
    Diabetes Metab. 2020;46:1-7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: